DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

AstraZeneca Pharma India Limited — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 1 hr ago·15 Aug 2026, 10:12 am

Company NSE

AstraZeneca Pharma India Limited has announced that it will host an institutional investor meet or conference call. This event is scheduled to take place in the near future, though the specific date has not been disclosed. The company has informed the stock exchanges to ensure transparency regarding the meeting.

For investors, such events are significant as they provide a platform for the company to communicate its future strategy, business outlook, and performance directly to analysts and large shareholders. It helps in aligning market expectations and clarifying any queries regarding the company's growth plans.

Investors should watch for updates on the company’s pipeline, sales performance, and management commentary during the meeting. Following the call, the stock may react based on the information shared, so keeping an eye on the company's official filings and subsequent market reaction is advisable.